Drugs Controller Proposes ‘Single-window Online Portal’ to Regulate Medicines, Cosmetics, Medical Devices

In what is likely to be a major overhaul of the system, a critical suggestion is to maintain a database of ‘not of standard quality’, spurious, adulterated or misbranded products in the public domain